Cargando…

Network-Based Inference Methods for Drug Repositioning

Mining potential drug-disease associations can speed up drug repositioning for pharmaceutical companies. Previous computational strategies focused on prior biological information for association inference. However, such information may not be comprehensively available and may contain errors. Differe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Hailin, Zhang, Heng, Zhang, Zuping, Cao, Yiqin, Tang, Wenliang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4410541/ https://www.ncbi.nlm.nih.gov/pubmed/25969690 http://dx.doi.org/10.1155/2015/130620

Ejemplares similares

A miRNA-Driven Inference Model to Construct Potential Drug-Disease Associations for Drug Repositioning
por: Chen, Hailin, et al.
Publicado: (2015)

In silico drug repositioning based on integrated drug targets and canonical correlation analysis
por: Chen, Hailin, et al.
Publicado: (2022)

In silico drug repositioning based on the integration of chemical, genomic and pharmacological spaces
por: Chen, Hailin, et al.
Publicado: (2021)

miRDDCR: a miRNA-based method to comprehensively infer drug-disease causal relationships
por: Chen, Hailin, et al.
Publicado: (2017)

Prediction of Drug-Target Interactions and Drug Repositioning via Network-Based Inference
por: Cheng, Feixiong, et al.
Publicado: (2012)

A Semi-Supervised Method for Drug-Target Interaction Prediction with Consistency in Networks
por: Chen, Hailin, et al.
Publicado: (2013)

Pathway-based drug repositioning using causal inference
por: Li, Jiao, et al.
Publicado: (2013)

MNBDR: A Module Network Based Method for Drug Repositioning
por: Chen, He-Gang, et al.
Publicado: (2020)

Similarity-based methods for potential human microRNA-disease association prediction
por: Chen, Hailin, et al.
Publicado: (2013)

Drug Repositioning for Diabetes Based on 'Omics' Data Mining
por: Zhang, Ming, et al.
Publicado: (2015)

Network mirroring for drug repositioning
por: Park, Sunghong, et al.
Publicado: (2017)

Novel human microbe-disease associations inference based on network consistency projection
por: Zou, Shuai, et al.
Publicado: (2018)

Prediction of Associations between OMIM Diseases and MicroRNAs by Random Walk on OMIM Disease Similarity Network
por: Chen, Hailin, et al.
Publicado: (2013)

Guiding Drug Repositioning for Cancers Based on Drug Similarity Networks
por: Qin, Shimei, et al.
Publicado: (2023)

Drug repositioning using drug-disease vectors based on an integrated network
por: Lee, Taekeon, et al.
Publicado: (2018)

PROMISCUOUS: a database for network-based drug-repositioning
por: von Eichborn, Joachim, et al.
Publicado: (2011)

Network module‐based drug repositioning for pulmonary arterial hypertension
por: Wang, Rui‐Sheng, et al.
Publicado: (2021)

Drug Repositioning with GraphSAGE and Clustering Constraints Based on Drug and Disease Networks
por: Zhang, Yuchen, et al.
Publicado: (2022)

Repositioned Drugs for Chagas Disease Unveiled via Structure-Based Drug Repositioning
por: Adasme, Melissa F., et al.
Publicado: (2020)

Drug repositioning based on weighted local information augmented graph neural network
por: Meng, Yajie, et al.
Publicado: (2023)

Topological network measures for drug repositioning
por: Badkas, Apurva, et al.
Publicado: (2020)

Rational drug repositioning for coronavirus-associated diseases using directional mapping and side-effect inference
por: Wang, Jianhua, et al.
Publicado: (2022)

Construction of Drug Network Based on Side Effects and Its Application for Drug Repositioning
por: Ye, Hao, et al.
Publicado: (2014)

Enriching limited information on rare diseases from heterogeneous networks for drug repositioning
por: Cao, Hongkui, et al.
Publicado: (2021)

Network neighborhood operates as a drug repositioning method for cancer treatment
por: Cüvitoğlu, Ali, et al.
Publicado: (2023)

A survey of optimal strategy for signature-based drug repositioning and an application to liver cancer
por: Yang, Chen, et al.
Publicado: (2022)

System and network biology-based computational approaches for drug repositioning
por: Pandita, Vasundhara, et al.
Publicado: (2022)

Drug Target Prediction and Repositioning Using an Integrated Network-Based Approach
por: Emig, Dorothea, et al.
Publicado: (2013)

MD-Miner: a network-based approach for personalized drug repositioning
por: Wu, Haoyang, et al.
Publicado: (2017)

Network determinants of cardiovascular calcification and repositioned drug treatments
por: Song, Euijun, et al.
Publicado: (2020)

Drug repositioning based on heterogeneous networks and variational graph autoencoders
por: Lei, Song, et al.
Publicado: (2022)

Computational drug repositioning through heterogeneous network clustering
por: Wu, Chao, et al.
Publicado: (2013)

Drug repositioning based on network-specific core genes identifies potential drugs for the treatment of autism spectrum disorder in children
por: Gao, Huan, et al.
Publicado: (2021)

HeTDR: Drug repositioning based on heterogeneous networks and text mining
por: Jin, Shuting, et al.
Publicado: (2021)

Drug Repositioning Based on the Enhanced Message Passing and Hypergraph Convolutional Networks
por: Huang, Weihong, et al.
Publicado: (2022)

Repositioning drugs by targeting network modules: a Parkinson’s disease case study
por: Yue, Zongliang, et al.
Publicado: (2017)

Prediction and interpretation of miRNA-disease associations based on miRNA target genes using canonical correlation analysis
por: Chen, Hailin, et al.
Publicado: (2019)

Concept Modeling-based Drug Repositioning
por: Patchala, Jagadeesh, et al.
Publicado: (2015)

Rational drug repositioning guided by an integrated pharmacological network of protein, disease and drug
por: Lee, Hee Sook, et al.
Publicado: (2012)

Computational drug repositioning using meta-path-based semantic network analysis
por: Tian, Zhen, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_av3t3iraiu1hg4qaao32m3i6u1